TrademarkDir
LEVELUP MEDS
LIVE

Serial Number

98868103

Owner

Delury Enterprise, LLC

Attorney

Sam Castree, III

First Use Date

May 1, 2026

Filing Date

Nov 22, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

LEVELUP MEDS Trademark

Serial Number: 98868103

LEVELUP MEDS is a trademark filed by Delury Enterprise, LLC on November 22, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Delury Enterprise, LLC (2 trademarks)

1110 E. Northshore Dr.
Syracuse, IN 46567

Entity Type: 16

Trademark Details

Filing Date

November 22, 2024

Registration Date

Not Registered

First Use Anywhere

May 1, 2026

First Use in Commerce

May 1, 2026

Published for Opposition

July 1, 2025

Goods & Services

Providing temporary use of a non-downloadable web application for tracking medicine consumption, facilitating communication between patients and caregivers, and facilitating communication between or among caregivers

Filing History

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 29, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 29, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 28, 2026 SUPC
USE AMENDMENT FILED
May 22, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
May 22, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 18, 2026 EXRA
SOU EXTENSION 1 GRANTED
Feb 17, 2026 EX1G
SOU EXTENSION 1 FILED
Feb 17, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 17, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 26, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 25, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 31, 2025 CNSA
ASSIGNED TO EXAMINER
May 15, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2025 NWOS
NEW APPLICATION ENTERED
Nov 22, 2024 NWAP

Related Trademarks

More from this Owner

LEVELUP MEDS

LEVELUP MEDS

LEVELUP MEDS

LEVELUP MEDS